Suppr超能文献

通过结膜单次接种羊布鲁氏菌Rev. 1疫苗对母羊进行疫苗接种。

Vaccination of ewes by a single conjunctival administration of Brucella melitensis Rev. 1 vaccine.

作者信息

Fensterbank R, Pardon P, Marly J

出版信息

Ann Rech Vet. 1985;16(4):351-6.

PMID:4091489
Abstract

In a lot of 99 ewes, the efficacy of a single vaccination by the conjunctival route (VC) with either 1.4 X 10(8) or 1.4 X 10(9) CFU Brucella melitensis Rev. 1 was compared with that of normal subcutaneous (SC) vaccination with 1.6 X 10(9) CFU. The ewes were challenged seven months after vaccination, when 85 days pregnant, with 5 X 10(7) CFU Brucella melitensis strain H38 administered by conjunctival route. Complement fixation, Rose Bengal and allergic tests were performed at intervals between vaccination and slaughter, and clinical and bacteriological examinations between challenge and slaughter, six weeks after lambing. After VC vaccination, few animals showed Brucella antibodies whatever the dose, and all were seronegative as early as four months after vaccination whereas a few SC vaccinated individuals were still seropositive at ten months. There were more allergic reactions among SC than VC animals, but sensitization was shown to be long-lasting in all vaccinated groups, whatever the administration route of the vaccine. VC vaccination with 10(9) CFU appeared to afford slightly greater protection than that with 10(8) CFU, and slightly lower protection than that induced by SC vaccination, but differences were not statistically significant. It is suggested that conjunctival vaccination with 10(9) CFU Rev. 1 would induce a good level of protection against Brucella melitensis infection and allow test and slaughter procedures as early as four months after vaccination.

摘要

在99只母羊中,比较了通过结膜途径(VC)单次接种1.4×10⁸或1.4×10⁹CFU 布鲁氏菌Melitensis Rev. 1的效果与正常皮下(SC)接种1.6×10⁹CFU的效果。母羊在接种疫苗七个月后,即怀孕85天时,通过结膜途径接种5×10⁷CFU布鲁氏菌Melitensis菌株H38进行攻毒。在接种疫苗至屠宰期间定期进行补体结合试验、玫瑰红试验和变态反应试验,在攻毒至屠宰期间,即产羔六周后进行临床和细菌学检查。结膜途径接种疫苗后,无论剂量如何,很少有动物出现布鲁氏菌抗体,并且早在接种疫苗四个月后所有动物均为血清阴性,而一些皮下接种的个体在十个月时仍为血清阳性。皮下接种的动物比结膜途径接种的动物出现更多的变态反应,但无论疫苗接种途径如何,所有接种组的致敏反应都显示出持续时间长。接种10⁹CFU结膜途径疫苗似乎比接种10⁸CFU提供的保护稍强,比皮下接种诱导的保护稍弱,但差异无统计学意义。建议接种10⁹CFU Rev. 1结膜途径疫苗可诱导对布鲁氏菌Melitensis感染的良好保护水平,并允许在接种疫苗四个月后尽早进行检测和屠宰程序。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验